Aligos Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
ALGS
CUSIP
01626L204
Type
Equity
Class
COM NEW
Num filings
39
Total reported value, excl. options
$19.5 M
Manager Report Date Value ($000) Shares Option Type